Top 4 Defensive Stocks That Could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Earnings Scheduled For November 30, 2023
Companies Reporting Before The Bell
• 111 (NASDAQ:YI) is projected to report earnings for its third quarter.
• Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.45 per share on revenue of $249.41 million.
This Online Healthcare Company Continues Its Winning Stride In Q2, Deal With Tencent A Cherry On The Cake
111 Inc (NASDAQ: YI) reported a Q2 FY23 net revenue increase of 14.5% Y/Y to
Earnings Scheduled For August 24, 2023
Companies Reporting Before The Bell
• 111 (NASDAQ:YI) is estimated to report earnings for its second quarter.
Earnings Scheduled For June 15, 2023
Companies Reporting Before The Bell
• 111 (NASDAQ:YI) is expected to report earnings for its first quarter.
• Aurora Mobile (NASDAQ:JG) is estimated to report earnings for its first quarter.
111 Clocks 24% Revenue Growth In Q1
111 Inc (NASDAQ: YI) reported a Q1 2023 net revenues increase of 23.9% Y/Y to ¥3.7 billion ($538.3 million), representing the 19th consecutive
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
111, Inc. Hosts Hua Medicine Launches First Official Flagship Store
On February 15, 2023, 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company in China, announced that during the HuaTangNing®
Charter Communications, Braze And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
iQIYI, Inc. (NASDAQ: IQ) shares dipped 14.1% to $3.31 in pre-market trading after gaining over 9% on Tuesday.
Reuters Reported Earlier China’s 111.inc App Starts Retail Sales of Pfizer’s Paxlovid for COVID
https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-111inc-app-starts-retail-sales-pfizers-paxlovid-covid-treatment-2022-12-13/